Medical Device News Magazine

Heraeus Nexensos Supports Vaccine Cold-chain Logistics with Temperature Sensors: Company Is Increasing Production Capacity to Meet the Demand

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Heraeus Nexensos advises providing a perfect cold chain for temperature-sensitive pharmaceutical products, such as vaccines and other biologicals, is a major logistical challenge for the pharmaceutical industry.  

Heraeus Nexensos platinum-based resistance temperature detectors (RTD) are a perfect fit for harsh cryogenic sensing applications. Heraeus RTD sensors provide reliable and accurate temperature measurement in dry ice (-78 °C), with capability down to -200 °C. Platinum RTDs exhibit extremely low drift, even after years of service, ensuring reliable data collection for the life of the measurement device. This reliability translates to precise monitoring of temperature-sensitive biochemical synthesis processes, and secure temperature control and monitoring for the complete cold chain logistic, from shipment to storage. 

“Heraeus sensors for cryogenic temperature measurement offer superior precision. More than 500 Million of delivered sensor elements have proven their reliability and outstanding performance in harsh environments. We are glad to support the efficacy and safety of cryo chains, especially for the logistics of vaccines against SARS-Cov-2.”, says Ralph Meschkat, President of Heraeus Nexensos. “We have already invested in 2020 in additional capacity and use this now to support increasing demand in this area. With our advanced planning system, we can now offer unmatched delivery times.” 

As the worldwide market and technology leader for platinum-based Resistance Temperature Sensors (RTD elements) Heraeus Nexensos offers its customers technical support in every major time zone in the world via application centers located in the US, China and Europe.  Sensor elements are available in tailormade sizes in support of various industrial applications. Nexensos’ production system and global inventories support short lead times and flexible supply arrangements.  

Platinum-based sensors are ideal for temperature measurement in challenging applications. The linear characteristics allow precise temperature sensing over the full measurement range. Applications include the monitoring of production process temperature stability, cryo-transport box temperature during transport, and ultra-low storage cooler temperature. Sensors are available for temperature measurement over a wide range from -200 to +1000 °C. Nexensos RTDs installed in harsh environments, such as automotive systems or power plants, exhibit a typical lifetime of 15 to 20 years.  

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”